Financial Performance - The company reported unaudited consolidated results for the six months ending June 30, 2024, compared to the same period in 2023[1]. - For the first half of 2024, the company reported total revenue of approximately RMB 25.20 million, a decrease of 1.69% compared to RMB 25.63 million in the same period last year[10]. - The company recorded a net loss of approximately RMB 2.97 million, compared to a net profit of RMB 0.11 million in the same period last year[10]. - Revenue from continuing operations for the six months ended June 30, 2024, was RMB 25,202 thousand, a decrease of 1.7% compared to RMB 25,634 thousand in the same period of 2023[51]. - Gross profit for the same period increased to RMB 12,681 thousand, up 31.5% from RMB 9,617 thousand year-on-year[51]. - The net loss from continuing operations for the six months ended June 30, 2024, was RMB 2,905 thousand, compared to a loss of RMB 540 thousand in the same period of 2023[51]. - The company reported a net cash outflow from operating activities of RMB 21,299 thousand for the six months ended June 30, 2024, compared to RMB 70,016 thousand in the same period of 2023[56]. - The total tax expense for the period was RMB 1,110,000, down from RMB 1,869,000 in the previous year, indicating a 40.5% reduction[74]. - Basic and diluted earnings per share from continuing operations were RMB 0.04, compared to a loss of RMB 0.04 in the previous year[76]. Corporate Governance - The announcement is in compliance with the GEM Listing Rules regarding preliminary announcements of interim results[1]. - The board of directors confirmed that the information provided in the announcement is accurate and complete in all material aspects[3]. - The company emphasizes the importance of good corporate governance for its success and sustainable development[46]. - The board is committed to fostering a corporate culture aligned with the company's vision and values[47]. - The company has adopted a code of conduct for securities trading by directors and supervisors, confirming compliance with trading standards[44]. - There were no changes in the information of directors and supervisors that require disclosure under GEM Listing Rules[45]. Market Position and Risks - The company is positioned in the GEM market, which is designed for small and medium-sized enterprises, indicating higher investment risks compared to larger companies listed on the main board[1]. - The company emphasizes the potential risks associated with investing in GEM-listed companies due to market volatility[1]. Assets and Liabilities - As of June 30, 2024, total assets were approximately RMB 486.05 million, a decrease of 0.10% from December 31, 2023[17]. - Total liabilities were approximately RMB 38.22 million, an increase of 6.92% from December 31, 2023, with a debt-to-equity ratio of approximately 8.53%[17]. - The company's current bank borrowings increased to RMB 10,000,000 as of June 30, 2024, up from RMB 5,000,000 as of December 31, 2023, reflecting a 100% increase in short-term financing[94]. - The total liabilities as of June 30, 2024, were RMB 19,539,000, slightly up from RMB 19,169,000 as of December 31, 2023, indicating a marginal increase of about 1.9%[94]. Employee and Management Information - The group had 86 full-time employees as of June 30, 2024, an increase of approximately 36.5% from 63 full-time employees a year earlier[23]. - Employee benefits expenses amounted to approximately RMB 0.94 million, an increase of about 37.1% compared to RMB 0.68 million in the previous year[23]. - Total management compensation for the six months ended June 30, 2024, was RMB 910 thousand, an increase from RMB 810 thousand for the same period in 2023, showing a growth of 12.35%[101]. Investments and Financial Assets - The company holds a 28.27% stake in Zhuhai Huheguangjing Venture Capital Fund, with an investment cost of RMB 30 million and a fair value of RMB 23.968 million as of June 30, 2024[29]. - The company also has a 9.9% stake in Beijing Shuncheng Health Investment Enterprise, with the same investment cost of RMB 30 million, but a fair value loss of RMB 2.67 million[29]. - The fair value income (loss) for the six months ended June 30, 2024, was RMB 23.968 million for Zhuhai Huheguangjing and a loss of RMB 2.67 million for Beijing Shuncheng Health[29]. - The fair value of financial assets measured at fair value through profit or loss increased to RMB 72,338,000 from RMB 63,102,000, reflecting a growth of 14.5%[78]. - The company has committed to invest RMB 6,000 thousand in a fund as of June 30, 2024, down from RMB 15,000 thousand as of December 31, 2023, indicating a reduction in capital commitments[102]. Revenue Segments - The financial and consulting segment generated revenue of RMB 11,699 thousand, up 73.5% from RMB 6,743 thousand in the prior year[61]. - The trading segment reported revenue of RMB 12,453 thousand, compared to no revenue in the same period last year[61]. - The energy storage segment contributed RMB 1,050 thousand in revenue, while it had no revenue in the previous year[61]. - The company has disposed of its 5G base station business segment, which is now classified as discontinued operations[60]. Cash Flow and Financing Activities - The net cash generated from financing activities was approximately RMB 4.23 million, compared to a net cash used of RMB 1.54 million in the previous year[18]. - The company reported a fair value gain of RMB 2,586,000 for financial assets related to a fund, with total investments amounting to RMB 30,000,000[80]. - The company has not engaged in any hedging transactions or forward contract arrangements during the reporting period[32]. Shareholder Information - Major shareholders include Beijing Dayuan Tiandi Real Estate Development Co., holding 66.67% of domestic shares, and Zhao Dehua, also holding 66.67%[36]. - The total number of shares issued by the company is 359,340,000, including 120,000,000 domestic shares, 89,840,000 H shares, and 149,500,000 non-listed foreign shares[38]. - The company does not recommend the payment of any interim dividend during the reporting period[41].
富银融资股份(08452) - 2024 - 中期业绩